Intrauterine devices incorporating nanocarriers for targeted cervical cancer therapy

用于靶向宫颈癌治疗的含纳米载体的宫内装置

阅读:1

Abstract

AIMS: Viruses are key contributors to many severe human illnesses. The majority of cervical cancer cases are linked to infection with the human papillomavirus (HPV). Current antiviral drug development strategies aim to interfere either with viral components or with specific host cell mechanisms. Combining the local biochemical actions of hormonal, antiviral, and chemotherapeutic agents can help in the prevention of viral infection and cancer appearance. MATERIAL AND METHODS: This work presents the injection molding of intrauterine devices (IUD) with progesterone, fluorouracil, and surfactant agents for drug delivery in prophylactic and infectious cervical cancer treatments. The IUDs were manufactured, and their properties were analyzed by electronic microscopy (SEM), infrared spectroscopy (FTIR), calorimetry (DSC), and mechanical tests. The drug release profiles and cell culture interactions were also investigated. RESULTS AND CONCLUSIONS: Polyethylene-based drug-loaded IUDs showed reproducible manufacturing, sustained drug release, and promising cytotoxic and antimicrobial activity, supporting their potential for localized cervical cancer treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。